Status:
COMPLETED
Increasing Stroke Treatment Through Interventional Change Tactics Study
Lead Sponsor:
University of Michigan
Collaborating Sponsors:
National Institute of Neurological Disorders and Stroke (NINDS)
Conditions:
Stroke
Eligibility:
All Genders
Phase:
NA
Brief Summary
The purpose of this study is to evaluate a standardized, system-based, barrier assessment and interactive educational intervention to increase appropriate t-PA use for stroke.
Detailed Description
Stroke is a major public health problem. Only 1 to 3 percent of people with stroke patients in community settings are receiving tissue plasminogen activator (t-PA) therapy ten years after it was appro...
Eligibility Criteria
Inclusion
- Physician staffed emergency department at all times
- 24/7 CT scanning availability
- Computerized pharmacy dispensing system for the emergency department or thrombolytic use log
- Agreement to participate and identified site investigator
Exclusion
- Primary children's, psychiatric, or long-term (convalescent) care hospital
- Established academic comprehensive stroke center (Detroit Receiving Hospital, Henry Ford Hospital, University of Michigan)
- Annual emergency department volume greater than 100,000 patients per year (only one hospital)
Key Trial Info
Start Date :
May 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2010
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT00349479
Start Date
May 1 2005
End Date
March 1 2010
Last Update
February 25 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Michigan, Department of Emergency Medicine
Ann Arbor, Michigan, United States, 48106